GlassScriptPhysician profile
Matthew William Lawrence
NPI 1093726101
$7,646.08
in general payments reported to CMS, 2019-2025
30 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $389 · 2021: $474 · 2022: $687 · 2023: $2,149 · 2024: $2,076 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,201 · Travel and Lodging: $1,446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,200.94 |
| Travel and Lodging | $1,445.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,490.08 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $1,052.88 | 2021-2025 | Endurant Iis, Hawkone, Abre |
| W. L. Gore & Associates, INC. | $576.85 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Penumbra, INC. | $542.07 | 2021-2025 | Indigo System, Penumbra System |
| Endologix LLC | $499.46 | 2022-2025 | Endocross Device, Torus Stent Graft System |
| Medtronic Vascular, INC. | $493.34 | 2019-2020 | |
| Boston Scientific Corporation | $387.74 | 2023-2025 | Enroute Transcarotid Neuroprotection System, Eluvia, Enroute Transcarotid Stent |
| Inari Medical, INC. | $310.04 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbvie INC. | $290.89 | 2023-2025 | |
| Cook Medical LLC | $224.13 | 2020-2021 | |
| Lemaitre Vascular, INC. | $194.74 | 2024 | Trivex System, Artegraft Vascular Graft |
| Artivion, INC. | $117.73 | 2019-2020 | |
| Abbott Laboratories | $112.23 | 2021 | |
| Tactile Systems Technology INC | $40.18 | 2024 | Flexitouch Plus, Entre Plus |
| Baxter Healthcare | $38.88 | 2023 | Perclot |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $29.16 | 2020-2023 | Enseal, Prolene, Ethicon |
| Bard Peripheral Vascular, INC. | $25.63 | 2020 | |
| Acera Surgical, INC. | $24.14 | 2025 | Restrata Wound Matrix |
| Kci USA, INC. | $23.12 | 2020 | |
| Cordis US Corp. | $22.17 | 2025 | Mynx Control |
| Davol INC. | $19.73 | 2023 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $19.37 | 2019 | |
| Cardinal Health 200 LLC | $19.34 | 2020 | |
| Angiodynamics, INC. | $16.59 | 2025 | Auryon Laser System 100-120 Vac |
| Avanos Medical | $14.71 | 2022 | |
| Paratek Pharmaceuticals, INC. | $13.80 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.77 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $12.43 | 2021 | |
| Cashflow Solutions, LLC | $11.81 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Medela LLC | $10.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.